Grogan Staging System for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Classifies prognosis of patients with wild-type transthyretin amyloid cardiomyopathy.
Advice
The staging and estimated prognosis should be used as part of a comprehensive evaluation to aid discussions about overall survival, treatment decisions, and the likelihood of response to treatment.